Skip to main content
. 2016 Apr 1;7(18):26454–26464. doi: 10.18632/oncotarget.8524

Figure 5. Representative four-fold immunofluorescence staining for CKneg/SOX-2pos cells after therapy of patient No1.

Figure 5

(A) Cell nuclei were stained with Dapi. (B) Indicates a CKneg cell. (C) Alludes a cell with SOX-2pos phenotype. (D) Shows CD34pos and/or CD45pos cells. (E) Indicates a merge of a DTC with the phenotype Dapipos, CKneg, SOX-2pos, CD34neg and CD45neg, magnification at 63×.

HHS Vulnerability Disclosure